OFI Advisors’s AstraZeneca AZN Stock Holding History

OFI Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$107K	Sell	1,678 -92	-5%	-$6.05K	0.01%	1455
2015 Q2	$113K	Buy	1,770 +223	+14%	+$15.3K	0.01%	1451
2015 Q1	$106K	Buy	1,547 +193	+14%	+$13.4K	0.01%	1482
2014 Q4	$95K	Buy	1,354 +57	+4%	+$4.08K	0.01%	1495
2014 Q3	$93K	Buy	1,297 +18	+1%	+$1.32K	0.01%	1476
2014 Q2	$95K	Sell	1,279 -156	-11%	-$11.3K	0.01%	1474
2014 Q1	$93K	Sell	1,435 -171	-11%	-$11K	0.01%	1445
2013 Q4	$95K	Sell	1,606 -231	-13%	-$12.5K	0.01%	1431
2013 Q3	$95K	Sell	1,837 -221	-11%	-$11.1K	0.01%	1350
2013 Q2	$97K	Buy	+2,058	New	+$105K	0.01%	1276

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

OFI Advisors's AZN Position: Q3 2015 in Review

OFI Advisors reduced its AstraZeneca (AZN) stake by 5.2% in Q3 2015, selling an estimated $6.05K and leaving 1,678 shares worth $107K. The position accounts for 0.01% of the portfolio, ranked #1455.

OFI Advisors first reported a position in AZN in Q2 2013 and has held it in 10 quarters since. The position peaked at $113K in Q2 2015. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

OFI Advisors held 1,678 shares of AstraZeneca worth $107K as of Q3 2015.
OFI Advisors sold 92 AstraZeneca shares in Q3 2015, an estimated $6.05K.
AstraZeneca made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1455 holding.
OFI Advisors first reported a position in AstraZeneca in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's AstraZeneca position peaked at $113K in Q2 2015.
371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.